Clinical Trial Update: A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor [Phase 1]

View source ↗

Summary

Phase 1 study of TQB3912 in patients with advanced malignant neoplasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• TQB3912

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Malignant Neoplasm | Phase 1 | Status: COMPLETED